CL2004000304A1 - Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un - Google Patents

Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un

Info

Publication number: CL2004000304A1
Authority: CL; Chile
Prior art keywords: pharmaceutically acceptable; acceptable salt; hydroxidifenylmetil; achetic; piperidinil
Prior art date: 1992-05-11

Application number

CL200400304A

Other languages

English (en)

Inventor

James K. Woodward

Richard R. Okerholm

Mark G Eller

Bruce E. Mcnutt

Original Assignee

Aventis Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-11

Filing date

2004-02-19

Publication date

2005-05-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27128589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000304(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-19 Application filed by Aventis Inc filed Critical Aventis Inc

2005-05-27 Publication of CL2004000304A1 publication Critical patent/CL2004000304A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CL200400304A 1992-05-11 2004-02-19 Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un CL2004000304A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88080192A	1992-05-11	1992-05-11
US92289092A	1992-07-31	1992-07-31

Publications (1)

Publication Number	Publication Date
CL2004000304A1 true CL2004000304A1 (es)	2005-05-27

Family

ID=27128589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200400304A CL2004000304A1 (es)	1992-05-11	2004-02-19	Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un

Country Status (16)

Country	Link
US (7)	US6037353A (es)
EP (1)	EP0639976B1 (es)
JP (1)	JPH07506828A (es)
KR (1)	KR950701525A (es)
AT (1)	ATE194913T1 (es)
AU (1)	AU679910B2 (es)
CA (1)	CA2134211C (es)
CL (1)	CL2004000304A1 (es)
DE (1)	DE69320952T2 (es)
DK (1)	DK0639976T3 (es)
ES (1)	ES2121084T3 (es)
HU (1)	HU223774B1 (es)
MX (1)	MX9302704A (es)
NO (1)	NO307688B1 (es)
NZ (1)	NZ251834A (es)
WO (1)	WO1993023047A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU223774B1 (hu) *	1992-05-11	2005-01-28	Merrell Dow Pharmaceuticals Inc.	Terfenadinszármazékok alkalmazása antihisztamin hatású gyógyszerkészítmények előállítására
PT815860E (pt) †	1992-08-03	2006-08-31	Sepracor Inc	Carboxilato de terfenadina e tratamento de desordens alergicas.
WO1995010278A1 (en) *	1993-10-15	1995-04-20	Hoechst Marion Roussel, Inc.	Treatment of allergic disorders with terfenadine carboxylate
IT1271417B (it) *	1993-10-15	1997-05-28	Erregierre Ind Chim	Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
DE69527429T2 (de) *	1994-05-18	2003-03-20	Aventis Pharmaceuticals Inc., Bridgewater	Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
US20030045722A1 (en) *	1994-05-18	2003-03-06	Henton Daniel R.	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
AU701042B2 (en) *	1995-02-28	1999-01-21	Aventisub Llc	Pharmaceutical composition for piperidinoalkanol compounds
SK283803B6 (sk) *	1997-08-26	2004-02-03	Aventis Pharmaceuticals Inc.	Farmaceutický prostriedok vo forme dvojvrstvovej tabletky na kombinovanie piperidinoalkanolu s dekongestantom
US6194431B1 (en)	1998-04-14	2001-02-27	Paul D. Rubin	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US20030021849A1 (en) *	2001-04-09	2003-01-30	Ben-Zion Dolitzky	Polymorphs of fexofenadine hydrochloride
US20020177608A1 (en) *	2001-04-09	2002-11-28	Ben-Zion Dolitzky	Polymorphs of fexofenadine hydrochloride
EP2316468A1 (en)	2002-02-22	2011-05-04	Shire LLC	Delivery system and methods for protecting and administering dextroamphetamine
AU2003248657A1 (en) *	2002-06-10	2003-12-22	Teva Pharmaceutical Industries Ltd.	Polymorphic form xvi of fexofenadine hydrochloride
EP1393728A1 (en) *	2002-08-30	2004-03-03	Vrije Universiteit	Inverse agonists acting at virus-encoded G protein-coupled receptors
US20050065183A1 (en) *	2003-07-31	2005-03-24	Indranil Nandi	Fexofenadine composition and process for preparing
MXPA06012281A (es) *	2004-04-26	2007-07-18	Teva Pharma	Formas cristalinas de clorhidrato de fexofenadina y procesos para su preparacion.
EP1685106A2 (en) *	2004-09-28	2006-08-02	Teva Pharmaceutical Industries, Inc.	Fexofendadine crystal form and processes for its preparation thereof
US20090076080A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched fexofenadine
US20090304826A1 (en) *	2008-05-30	2009-12-10	Fairfield Clinical Trials, Llc	Method and composition for dermatoses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4254129A (en) *	1979-04-10	1981-03-03	Richardson-Merrell Inc.	Piperidine derivatives
US4285958A (en) *	1979-04-10	1981-08-25	Richardson-Merrell Inc.	1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
AR240018A1 (es) *	1987-10-07	1990-01-31	Merrell Pharma Inc	Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
US4929605A (en) *	1987-10-07	1990-05-29	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol derivatives
HU223774B1 (hu) *	1992-05-11	2005-01-28	Merrell Dow Pharmaceuticals Inc.	Terfenadinszármazékok alkalmazása antihisztamin hatású gyógyszerkészítmények előállítására
PT815860E (pt) *	1992-08-03	2006-08-31	Sepracor Inc	Carboxilato de terfenadina e tratamento de desordens alergicas.

1993
- 1993-04-06 HU HU9403234A patent/HU223774B1/hu active IP Right Grant
- 1993-04-06 NZ NZ251834A patent/NZ251834A/en not_active IP Right Cessation
- 1993-04-06 AT AT93909249T patent/ATE194913T1/de active
- 1993-04-06 WO PCT/US1993/003151 patent/WO1993023047A1/en not_active Ceased
- 1993-04-06 AU AU39734/93A patent/AU679910B2/en not_active Expired
- 1993-04-06 ES ES93909249T patent/ES2121084T3/es not_active Expired - Lifetime
- 1993-04-06 CA CA002134211A patent/CA2134211C/en not_active Expired - Lifetime
- 1993-04-06 JP JP5520211A patent/JPH07506828A/ja active Pending
- 1993-04-06 KR KR1019940704016A patent/KR950701525A/ko not_active Ceased
- 1993-04-06 DK DK93909249T patent/DK0639976T3/da active
- 1993-04-06 EP EP93909249A patent/EP0639976B1/en not_active Expired - Lifetime
- 1993-04-06 DE DE69320952T patent/DE69320952T2/de not_active Expired - Lifetime
- 1993-05-07 MX MX9302704A patent/MX9302704A/es unknown
1994
- 1994-11-10 NO NO944287A patent/NO307688B1/no not_active IP Right Cessation
1995
- 1995-03-02 US US08/397,542 patent/US6037353A/en not_active Expired - Lifetime
2000
- 2000-01-12 US US09/481,404 patent/US6187791B1/en not_active Expired - Fee Related
- 2000-02-11 US US09/502,331 patent/US20030055083A1/en not_active Abandoned
- 2000-09-15 US US09/663,343 patent/US6399632B1/en not_active Expired - Fee Related
2003
- 2003-02-25 US US10/372,307 patent/US20030130315A1/en not_active Abandoned
2004
- 2004-02-19 CL CL200400304A patent/CL2004000304A1/es unknown
2006
- 2006-05-15 US US11/433,433 patent/US20060205782A1/en not_active Abandoned
2009
- 2009-07-01 US US12/496,153 patent/US20100168166A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JPH07506828A (ja)	1995-07-27
MX9302704A (es)	1994-06-30
US6037353A (en)	2000-03-14
HU223774B1 (hu)	2005-01-28
DE69320952D1 (de)	1998-10-15
ATE194913T1 (de)	2000-08-15
US20030055083A1 (en)	2003-03-20
US20100168166A1 (en)	2010-07-01
ES2121084T3 (es)	2002-02-16
US6187791B1 (en)	2001-02-13
CA2134211C (en)	1999-06-29
WO1993023047A1 (en)	1993-11-25
US20060205782A1 (en)	2006-09-14
EP0639976B1 (en)	2000-07-26
US20030130315A1 (en)	2003-07-10
AU679910B2 (en)	1997-07-17
EP0639976A1 (en)	1995-03-01
DK0639976T3 (da)	1999-02-15
NO307688B1 (no)	2000-05-15
US6399632B1 (en)	2002-06-04
AU3973493A (en)	1993-12-13
HUT71402A (en)	1995-11-28
NZ251834A (en)	1997-07-27
DE69320952T2 (de)	1999-05-27
CA2134211A1 (en)	1993-11-25
KR950701525A (ko)	1995-04-28
NO944287L (no)	1994-11-10
NO944287D0 (no)	1994-11-10

Similar Documents

Publication	Publication Date	Title
CL2004000304A1 (es)	2005-05-27	Uso del acido 4-[1-hidroxi-4-[4-hidroxidifenilmetil)-1-piperidinil]butil]-alfa, alfa-dimetilbenceno acetico o una sal farmaceuticamente aceptable del mismo, para la preparacion de un medicamento util como antihistaminico, en pacientes que padecen un
CA2362337A1 (en)	1995-01-05	Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
ES2086270T5 (es)	2001-02-01	Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
IE851615L (en)	1985-12-29	Topical composition
FI935847A0 (fi)	1993-12-23	L-DOPA-esterkompositioner
ES2178430T3 (es)	2002-12-16	Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ATE219363T1 (de)	2002-07-15	Lösliche prodrugs von paclitaxel
UA41502C2 (uk)	2001-09-17	Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
FR2662162B1 (fr)	1995-01-20	Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2161238T3 (es)	2001-12-01	Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas.
ES2147788T3 (es)	2000-10-01	3,4-diarilcromanos para el tratamiento de la dermatitis.
CA2003289A1 (en)	1990-05-18	Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
ES2115571T3 (es)	2003-09-01	Uso de polisulfato de pentosana para la resolucion de cicatrices en enfermedades vasculares progresivas cronicas.
AR008559A1 (es)	2000-01-19	Uso de pentosanpolisulfato (pps) o de una sal farmaceuticamente aceptable del mismo
KR910015300A (ko)	1991-09-30	부스피론 : 수면 무호흡증의 치료용도
FR2691149B1 (fr)	1994-07-08	Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DE69414396D1 (de)	1998-12-10	Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
ATE275953T1 (de)	2004-10-15	2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
KR910015301A (ko)	1991-09-30	수면 무호흡증의 치료방법
UY23397A1 (es)	1993-04-21	Composicion y metodo de pro-droga de 5-fluorouracilo topica
FR2456100A1 (fr)	1980-12-05	Procede pour la preparation de composes du type pyrimidine condensee a tete de pont azotee, leurs sels, hydrates et isomeres, certains representants des composes prepares et compositions pharmaceutiques les contenant
FR2766184B1 (fr)	2000-11-17	Medicaments contenant en tant que principe actif au moins un derive de polyhydroxylalkylpyrazine, les nouveaux derives de polyhydroxylalkylpyrazine et leur preparation
NO961979D0 (no)	1996-05-14	Estramustin formuleringer med forbedrede farmasöytiske egenskaper
ES2058315T3 (es)	1994-11-01	Compuestos eficaces contra insuficiencia cerebral.